Figure 1.

Flow chart of the study. Six immune cells were screened by literature review and immunohistochemistry was performed in the training set (N = 113) and the validation set (N = 125). Five immune features were ultimately selected to construct the immune index model. The associations of immunotype with overall survival (OS) and chemotherapy benefit were sequentially tested in both sets